JUN and central nervous system cancer: We analyzed DNA methylation patterns at the JUN promoter and putative c-Jun regulated promoters (2 kb upstream/500 bp downstream relative to TSS) in GII/GIII-IDHwt and GIV glioma patients from the Glioma Atlas [4].